The impact of body mass index on the risk of postoperative complications following myomectomy
Further Publications Gynecology
Related content
Benign Prostatic Hyperplasia (BPH)
Metabolic syndrome is associated with postoperative complications after holmium laser enucleation of the prostate
BJU Int
Edmonds VS, Heidenberg DJ, Mayes C, Mead-Harvey C, Humphreys MR
doi: 10.1111/bju.16663
HPV and Gynecologic Cancer
Ovarian cancer risk among older patients with stable adnexal masses
Am J Obstet Gynecol
Suh-Burgmann EJ, Hung YY, Schmittdiel JA
doi: 10.1016/j.ajog.2024.04.019
Uro-Oncology
Artificial intelligence-based assessment of pre-operative body composition is associated with early complications after radical cystectomy
J Urol
Sharma V, Fadel A, Tollefson MK, Psutka SP, Blezek DJ, Frank I, Thapa P, Tarrell R, Viers LD, Potretzke AM, Hartman RP, Boorjian SA, Viers BR
doi: 10.1097/JU.0000000000004292
COMMENTED
Uro-Oncology
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Further Publications Urology
Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis-a systematic review including meta-analysis of all comparative studies
Prostate Cancer Prostatic Dis
Wolff I, Büchner M, Hauner K, Wagenlehner F, Burchardt M, Abele-Horn M, Wullich B, Gilfrich C, Pilatz A, May M
doi: 10.1038/s41391-024-00934-9
Further Publications Gynecology
The 36-week preeclampsia risk by the Fetal Medicine Foundation algorithm is associated with fetal compromise following induction of labor
Am J Obstet Gynecol
Farina A, Cavoretto PI, Syngelaki A, Morano D, Adjahou S, Nicolaides KH
doi: 10.1016/j.ajog.2024.12.025
Uro-Oncology
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial
Eur Urol
Krilaviciute A, Kaaks R, Seibold P, de Vrieze M, Lakes J, Radtke JP, Kuczyk M, Harke NN, Debus J, Fink CA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Antoch G, Giesel FL, Makowski M, Wacker F, Schlemmer HP, Becker N, Albers P
doi: 10.1016/j.eururo.2024.04.030
Uro-Oncology
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
Eur Urol
Ravi P, Xie W, Buyse M, Halabi S, Kantoff PW, Sartor O, Attard G, Clarke N, D'Amico A, Dignam J, James N, Fizazi K, Gillessen S, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ
doi: 10.1016/j.eururo.2024.04.038
Uro-Oncology
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
BJU Int
Bancroft EK, Page EC, Brook MN, Pope J, Thomas S, Myhill K, Helfand BT, Talaty P, Ong KR, Douglas E, Cook J, Rosario DJ, Salinas M, Buys SS, Anson J, Davidson R, Longmuir M, Side L, Eccles DM, Tischkowitz M, Taylor A, Cruellas M, Ballestero EP, Cleaver R, Varughese M, Barwell J, LeButt M, Greenhalgh L, Hart R, Azzabi A, Jobson I, Cogley L, Evans DG, Rothwell J, Taylor N, Hogben M, Saya S, IMPACT Study Steering Committee; IMPACT Collaborators, Eeles RA, Aaronson NK
doi: 10.1111/bju.16432